These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21737604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ITP, interrupted.
    Stasi R.
    Blood; 2011 Oct 20; 118(16):4297-8. PubMed ID: 22021448
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel thrombopoietic agents: preliminary activity, potential benefit.
    Bussel JB.
    J Support Oncol; 2007 Apr 20; 5(4 Suppl 2):63-84. PubMed ID: 17550056
    [No Abstract] [Full Text] [Related]

  • 5. FDA approves thrombopoiesis-stimulating agent.
    Thompson CA.
    Am J Health Syst Pharm; 2008 Oct 01; 65(19):1788. PubMed ID: 18796411
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of chronic immune thrombocytopenia in children with romiplostim.
    Chaturvedi S, McCrae KR.
    Lancet; 2016 Jul 02; 388(10039):4-6. PubMed ID: 27103125
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Salvage therapy of autoimmune thrombocytopenic purpura revealing non-Hodgkin lymphoma by the thrombopoietin receptor agonist romiplostim.
    Al-Nawakil C, Park S, Chapuis N, Dreyfus F, Szwebel TA, Gibault L, Molina T, Hermine O, Bouscary D, Tamburini J.
    Br J Haematol; 2012 Jan 02; 156(1):145-7. PubMed ID: 21848881
    [No Abstract] [Full Text] [Related]

  • 13. [New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists].
    Khellaf M.
    Rev Med Interne; 2009 Oct 02; 30(9 Suppl):13-5. PubMed ID: 19874983
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.
    Veneri D, Soligo L, Pizzolo G, Ambrosetti A.
    Blood Transfus; 2015 Oct 02; 13(4):694-5. PubMed ID: 26057496
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Remissions after long-term use of romiplostim for immune thrombocytopenia.
    Marshall AL, Scarpone R, De Greef M, Bird R, Kuter DJ.
    Haematologica; 2016 Dec 02; 101(12):e476-e478. PubMed ID: 27587382
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.